Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by schemehatcheron Aug 11, 2014 1:14pm

216 Views

Post# 22828891

"It's not our time just yet Forrest"

Ku-joes to the job being done on Tekmira.

Phase I, only used on animals to date.

Here, we have new posters explaining why we are well south of a 50 million market cap.

I'll betcha $5 some of the "ebola $" makes it's way to sepsis.

Interesting to watch, but then again so is a lava lamp.

The Canadian bio space is tight and well managed....see analyst speaking on BNN and telling people SDI only rose to .77 on "excitement in bio-space"

Nothing to do with a "halted phase II for eficacy", a proven theranostic device with a personalized medical application.......can you say 45 MILLION NON-BROKERED ??

Where do I pay $30 for a phase I ebola investment ? What a JOKE !!

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading